跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
AZITHROMYCIN KERN PHARMA 200MG/5ML POWDER FOR ORAL SUSPENSION
Approved
THERAPEUTIC
AZITHROMYCIN KERN PHARMA 200MG/5ML POWDER FOR ORAL SUSPENSION
KERN PHARMA, S. L. (SPAIN)
🇸🇬 Health Sciences Authority
Approval Date
Jun 20, 2011
Approval ID
f4e2d3997626d87e
Company
KERN PHARMA, S. L. (SPAIN)
Type
Therapeutic
Approval Details
Approval Id
f4e2d3997626d87e
Drug Name
AZITHROMYCIN KERN PHARMA 200MG/5ML POWDER FOR ORAL SUSPENSION
Product Name
AZITHROMYCIN KERN PHARMA 200MG/5ML POWDER FOR ORAL SUSPENSION
Approval Number
SIN13977P
Approval Date
2011-06-20
Registrant
APOTHECA MARKETING PTE LTD
Licence Holder
APOTHECA MARKETING PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
POWDER, FOR SUSPENSION
Route Of Administration
ORAL
Atc Code
J01FA10
Atc Item Name
azithromycin
Pharma Manufacturer Name
APOTHECA MARKETING PTE LTD
Active Ingredients
AZITHROMYCIN DIHYDRATE 209.62 mg/5 ml EQV AZITHROMYCIN ANHYDROUS
200 mg/5 ml
AZITHROMYCIN DIHYDRATE 209.62 MG/5 ML EQV AZITHROMYCIN ANHYDROUS
200 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 20, 2011
Approval ID
f4e2d3997626d87e
Type
Therapeutic
Back to HSA Approvals
AZITHROMYCIN KERN PHARMA 200MG/5ML POWDER FOR ORAL SUSPENSION - HSA Drug Approval Details
